DOI QR코드

DOI QR Code

Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner

  • Chang, Jee Suk (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Yoon, Hong In (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Cha, Hye Jung (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Chung, Yoonsun (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Cho, Yeona (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Keum, Ki Chang (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Koom, Woong Sub (Department of Radiation Oncology, Yonsei University College of Medicine)
  • Received : 2013.01.22
  • Accepted : 2013.02.26
  • Published : 2013.03.31

Abstract

Purpose: To describe the early experience of analyzing variations and time trends in bladder volume of the rectal cancer patients who received bladder ultrasound scan. Materials and Methods: We identified 20 consecutive rectal cancer patients who received whole pelvic radiotherapy (RT) and bladder ultrasound scan between February and April 2012. Before simulation and during the entire course of treatment, patients were scanned with portable automated ultrasonic bladder scanner, 5 times consecutively, and the median value was reported. Then a radiation oncologist contoured the bladder inner wall shown on simulation computed tomography (CT) and calculated its volume. Results: Before simulation, the median bladder volume measured using simulation CT and bladder ultrasound scan was 427 mL (range, 74 to 1,172 mL) and 417 mL (range, 147 to 1,245 mL), respectively. There was strong linear correlation (R = 0.93, p < 0.001) between the two results. During the course of treatment, there were wide variations in the bladder volume and every time, measurements were below the baseline with statistical significance (12/16). At 6 weeks after RT, the median volume was reduced by 59.3% to 175 mL. Compared to the baseline, bladder volume was reduced by 38% or 161 mL on average every week for 6 weeks. Conclusion: To our knowledge, this study is the first to prove that there are bladder volume variations and a reduction in bladder volume in rectal cancer patients. Moreover, our results will serve as the basis for implementation of bladder training to patients receiving RT with full bladder.

References

  1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40. https://doi.org/10.1056/NEJMoa040694
  2. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701. https://doi.org/10.1097/01.sla.0000257358.56863.ce
  3. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009;373:811-20. https://doi.org/10.1016/S0140-6736(09)60484-0
  4. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30:1926-33. https://doi.org/10.1200/JCO.2011.40.1836
  5. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-304. https://doi.org/10.1016/S0140-6736(01)06409-1
  6. Douglass HO Jr, Moertel CG, Mayer RJ, et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-5. https://doi.org/10.1056/NEJM198611133152014
  7. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-30. https://doi.org/10.1200/JCO.2009.22.0467
  8. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-5. https://doi.org/10.1200/JCO.2006.06.7629
  9. Kavanagh BD, Pan CC, Dawson LA, et al. Radiation dosevolume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S101-7. https://doi.org/10.1016/j.ijrobp.2009.05.071
  10. Drzymala M, Hawkins MA, Henrys AJ, et al. The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer. Br J Radiol 2009;82:321-7. https://doi.org/10.1259/bjr/57848689
  11. Nijkamp J, Doodeman B, Marijnen C, Vincent A, van Vliet-Vroegindeweij C. Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board. Radiother Oncol 2012;102:22-9. https://doi.org/10.1016/j.radonc.2011.05.076
  12. Kim TH, Chie EK, Kim DY, et al. Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 2005;62:769-75. https://doi.org/10.1016/j.ijrobp.2004.11.015
  13. Park W, Huh SJ, Lee JE, et al. Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer. Gynecol Oncol 2005;99:645-51. https://doi.org/10.1016/j.ygyno.2005.07.018
  14. Nakamura N, Shikama N, Takahashi O, et al. Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer. Strahlenther Onkol 2010;186:637-42. https://doi.org/10.1007/s00066-010-2105-6
  15. Ahmad R, Hoogeman MS, Quint S, Mens JW, de Pree I, Heijmen BJ. Inter-fraction bladder filling variations and time trends for cervical cancer patients assessed with a portable 3-dimensional ultrasound bladder scanner. Radiother Oncol 2008;89:172-9. https://doi.org/10.1016/j.radonc.2008.07.005
  16. Yoon HI, Chung Y, Kim JH, et al. The efficacy of the change in belly board aperture location by the addition of bladder compression device for radiotherapy of rectal cancer. J Korean Soc Ther Radiol Oncol 2010;28:231-7. https://doi.org/10.3857/jkstro.2010.28.4.231
  17. Stam MR, van Lin EN, van der Vight LP, Kaanders JH, Visser AG. Bladder filling variation during radiation treatment of prostate cancer: can the use of a bladder ultrasound scanner and biofeedback optimize bladder filling? Int J Radiat Oncol Biol Phys 2006;65:371-7. https://doi.org/10.1016/j.ijrobp.2005.12.039
  18. O'Doherty UM, McNair HA, Norman AR, et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 2006;79:335-40. https://doi.org/10.1016/j.radonc.2006.05.007
  19. Hynds S, McGarry CK, Mitchell DM, et al. Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer. Br J Radiol 2011;84:813-8. https://doi.org/10.1259/bjr/50048151